What We Test
iGene® provides superior accuracy for the screening of Trisomy 21, 18, 13, sex chromosome aneuploidies and deletion syndromes. iGene® is suitable for at-risk expectant mothers who may be considering, or have been offered, invasive prenatal diagnostic testing for fetal trisomy.
While the iGene® test can be done as early as 10 weeks, we recommend waiting till the 12th week, when the pregnancy is more stable.
View what a mother has to say about our test:
For patients in Australia, please click here to view the iGene test coverage
Click here to learn more about Chromosomal Abnormalities tested